GreenLight Biosciences
GRNA
P/S ratio for GreenLight Biosciences (GRNA)
P/S ratio as of May 2024 (TTM): 4.45
According to GreenLight Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.45202. At the end of 2023 the company had a P/S ratio of 6.43.
P/S ratio history for GreenLight Biosciences from 2022 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 6.43 | -77.05% |
| 2022 | 28.0 |